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PathExpand: Extending biological pathways 
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Overview:
• Introduction / Motivation
• Pathway extension procedure and criteria
• Validation methods












































































PathExpand Page 3 of 22
Introduction
Introduction / Motivation:













































































Rich sources of information,
but partly subjective and
inconsistent.
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Goals




 large-scale, less biased
Questions / Goals:
• Can we improve pathway
definitions (compactness,
connectivity, density)?
• How are pathways
communicating (“cross-talk”)?
Human unweighted binary 
protein interaction network
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Data representation / integration
Model data as a graph G=(V,E):
V:= molecules; E:= interactions
Molecular interactions:
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Pathway extension procedure and criteria:
How do we recognize “good” pathway
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PPI-based pathway extension
Extend pathways by adding genes that are „strongly connected“ to the 
pathway-nodes or increase the pathway-“compactness“ in a PPI.
Pathway extension criteria: Add a node v to set P if:
• v has a pathway-neighbour and degree(v) > 1; and
• #pathway-links(v,p) / #outside-links(v,p) > T1; or
• #triangle-links(v,p) / #possible_triangles(v,p) > T2; or
• #pathway-links(v,p) / #pathway-nodes(p) > T3; and
• avg. shortest path distance in {P,v} smaller than in P
black = pathway-nodes
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Example pathway extension
Example extension:
Pathway: BioCarta “BTG family proteins and cell cycle regulation“
original pathway
added nodes
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Validation:
How to validate pathway extensions
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Evaluation (1)
Cross-validation
Can randomly deleted genes in the original pathways be recovered
by the expansion procedure?
 3-step cross-validation procedure:
1. Randomly remove 10% of the pathway members (among
proteins with at least one partner in the pathway)
2. Apply the proposed extension procedure as well as 100
random extensions (random sampling among candidates)





































































PathExpand Page 12 of 22
Evaluation (2)
Semantic similarity analysis (Gene Ontology)
• Quantify pairwise 
similarities between 
protein annotations 
using Jiang & Conrath‘s
semantic similarity 
measure for GO-terms
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Extension statistics
Extension statistics across all databases
Statistics on added proteins across 3 pathway databases:
 pathways increase to 113% - 126% of original size
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Topological Analysis
Topological properties of added proteins
Network topological properties for proteins added to BioCarta pathways
The added proteins are more central, more densily clustered and
have shorter distances between them in comparison to matched-
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Biological application:
Which insights do we gain when applying
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Biological results (1)
• More than 20 proteins
annotated in our
PPI-network
• 5 proteins added by the 
extension process (circled)
• 3 known to be associated
with the disease
• 2 novel candidates:
METTL2B, TMED10
Application: Alzheimer disease pathway
KEGG Alzheimer disease pathway 
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Biological results (2)
• Complex system of
intracellular signalling
cascades
• New putative pathway 
regulators identified 
• New “crosstalk proteins”
identified (associated
with multiple pathways)
Application: Interleukin signalling pathways
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Biological results (3)
Using extended pathways for functional 
enrichment analysis
• classical approach:
Test enrichment of experimentally derived gene sets in 
cellular pathway members (one-sided Fisher exact test)
 idea: replace original pathways by extended versions
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Cancer mutated genes
Pancreatic mutated genes in expanded pathways
• “Cell cycle G1/S check 
point process” - extension 
procedure adds 7 proteins
• 6 of the added proteins are 
involved in cell cycle regulation
• the 7th (TGIF2) is known to be
mutated in pancreatic cancer
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Comparison to previous methods





Shamir & Ulitsky (2007)
Ma & Tarone & Li (2008)
Brady et al. (2009)
Cerami et al. (2010)
Nitsch et al. (2009)
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Conclusion
• The method integrates two sources of information, 
extending canonical pathways using large-scale 
protein interaction data
• Three validation methods: cross-validation, GO-term
semantic similarity and enrichment analysis
• Extended pathways have advantages in terms of 
network-compactness and can provide new insights 
on pathway regulators, the cross-talk between 
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